Cargando…

EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis

Aim: BAP1 is frequently mutated in clear cell renal cell carcinoma (ccRCC) with a definitive role still unclear. Methods: In silico analysis of BAP1-mutant and wild-type gene enrichment and functional annotation in TCGA-KIRC dataset was performed. Target gene was studied based on functional clusteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chenmin, Zhao, Chunchun, Li, Shugen, Wang, Jianqing, Zhou, Qidong, Sun, Jianliang, Ding, Qiang, Liu, Min, Ding, Guanxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215999/ https://www.ncbi.nlm.nih.gov/pubmed/30405850 http://dx.doi.org/10.7150/jca.26275

Ejemplares similares

Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019)

Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
por: Ding, Guanxiong, et al.
Publicado: (2020)

HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
por: Wang, Jianqing, et al.
Publicado: (2019)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
por: Tan, Guobin, et al.
Publicado: (2020)

Loss of BAP1 function leads to EZH2-dependent transformation
por: LaFave, Lindsay M., et al.
Publicado: (2015)

Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma
por: LIU, LUNZHI, et al.
Publicado: (2014)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma
por: Duan, Junyao, et al.
Publicado: (2019)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
por: Fu, Yang, et al.
Publicado: (2019)

Effects of BAP1, Ki-67 index, and Id-1 in patients with clear cell renal carcinoma and their correlation with clinical features and prognosis
por: Yang, Jing, et al.
Publicado: (2020)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022)

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
por: Ge, Yu-Zheng, et al.
Publicado: (2017)

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
por: Feng, Zhan, et al.
Publicado: (2020)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma
por: Niu, Tian, et al.
Publicado: (2016)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Gao, Yuan, et al.
Publicado: (2020)

HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer
por: Lu, Wei, et al.
Publicado: (2020)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
por: Zhang, Qi, et al.
Publicado: (2019)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study
por: Wu, Xin-Qiang, et al.
Publicado: (2022)

BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
por: Kuznetsov, Jeffim N., et al.
Publicado: (2019)

High Expression of CD39 is Associated with Poor Prognosis and Immune Infiltrates in Clear Cell Renal Cell Carcinoma
por: Wu, Jie, et al.
Publicado: (2020)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma
por: Wi, Young Chan, et al.
Publicado: (2018)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Increased phosphorylated CREB1 protein correlates with poor prognosis in clear cell renal cell carcinoma
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Yao, Yicong, et al.
Publicado: (2021)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Asada, Shuhei, et al.
Publicado: (2018)

High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
por: Chen, Zhitao, et al.
Publicado: (2022)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Kurota, Yuta, et al.
Publicado: (2023)

Increased Expression of Pregnancy Up-Regulated Non-Ubiquitous Calmodulin Kinase Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Song, et al.
Publicado: (2013)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q4e4kvkods265po9qpq9omi863